Cyramza 100 MG/10 ML vial 10ML
Ended Awarded
- Contract number
- SPE2DB25FL1T2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,389
Award facts
- Contract value 100% obligated
- $10,388.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,388.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Cyramza 100 mg/10 mL vials. This firm fixed-price delivery order, issued on August 14, 2025, with an ultimate completion date of September 5, 2025, represents a continuation of the agencies' pharmaceutical supply chain operations. The award was issued without a set-aside designation, demonstrating DMS Pharmaceutical Group's competitive strength in open federal procurement markets despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 through November 2026. The parent contract, operating under the SPE2DB program, authorizes the issuance of firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facility medical supply needs worldwide. DMS Pharmaceutical Group's established role as a critical supplier in the federal pharmaceutical supply chain positions the company to fulfill specialized pharmaceutical requirements, such as this Cyramza delivery, which supports oncology treatment capabilities across Department of Defense healthcare facilities.
Quick answers
Who was awarded contract SPE2DB25FL1T2?
SPE2DB25FL1T2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 14, 2025.
How much is contract SPE2DB25FL1T2 worth?
The government has obligated $10,389 on SPE2DB25FL1T2.
Is contract SPE2DB25FL1T2 an order under another contract?
Yes. SPE2DB25FL1T2 is a delivery order under SPE2DB20D9331, an indefinite delivery contract.
Was contract SPE2DB25FL1T2 competed?
The extent of competition for SPE2DB25FL1T2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award